ICCC
ImmuCell Corporation
9.90$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.0% | 28.4% | -3.4% | 11.3% | -3.4% | 1.7% | 8.6% | 5.0% | -8.3% | -26.8% | 1.4% | 9.0% | |
| 5.9% | 5.2% | 8.4% | 8.7% | 13.8% | 16.5% | 15.3% | 12.8% | 13.4% | 15.6% | 10.1% | 9.9% | |
| 0.4% | 0.2% | 0.7% | 1.9% | 3.1% | 2.3% | 1.6% | 0.7% | 1.4% | 2.1% | 1.2% | 1.1% | |
| -0.7% | 8.2% | 3.5% | -0.7% | 1.1% | 2.6% | -4.2% | 1.0% | 1,547.7% | – | – | – | |
| 1.0% | 3.1% | -20.7% | 5.1% | 2.8% | -8.0% | 3.5% | -8.4% | -9.9% | -12.1% | -1.5% | -7.4% | |
| 20.2% | 26.6% | 37.6% | 170.3% | 18.5% | 10.1% | 26.5% | 13.6% | 21.4% | 10.8% | 1.8% | 4.5% | |
| -20.2% | -45.2% | -46.3% | -117.7% | -16.3% | -24.8% | -16.8% | -8.3% | -21.4% | -10.8% | -1.7% | -4.4% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.0% | 1.2% | 89.1% | 36.6% | 0.9% | 60.5% | 0.0% | – | – | – | – | – | |
| -2.5% | 22.4% | -1.9% | 56.8% | 7.2% | -9.9% | 12.8% | -1.9% | 5,939.7% | 10.4% | -5.5% | -5.4% | |
| -2.5% | 23.9% | 87.2% | 93.4% | 8.1% | 50.6% | 12.5% | 20.2% | 6.0% | 10.0% | 10.9% | -4.4% | |
| -18.7% | 7.1% | 37.5% | -13.0% | -11.6% | 27.5% | 4.3% | 16.8% | -23.7% | -27.5% | 10.5% | 0.2% | |
| -16.2% | 1.8% | -41.0% | -159.0% | -21.9% | -8.4% | -18.0% | -8.6% | -29.7% | -37.6% | -0.4% | 4.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.